EMvision Medical Devices Ltd. (EMV) Price & Analysis

Compare

6 Followers

EMV Stock Chart & Stats

AU$1.77

-AU$0.06(-3.19%)

At close: Jan 09 4:00 PM EST

AU$1.77

-AU$0.06(-3.19%)

Day’s Range― - ―

52-Week RangeAU$1.56 - AU$2.43

Previous CloseN/A

Volume36.00K

Average Volume (3M)120.98K

Market Cap

AU$146.84M

Enterprise ValueAU$133.32M

Total Cash (Recent Filing)AU$17.56M

Total Debt (Recent Filing)AU$4.02M

Price to Earnings (P/E)―

Beta0.61

Next Earnings

Sep 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.04

Shares Outstanding92,938,610

10 Day Avg. Volume127,185

30 Day Avg. Volume120,982

Financial Highlights & Ratios

PEG Ratio-0.07

Price to Book (P/B)16.01

Price to Sales (P/S)29.42

P/FCF Ratio-18.85

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$3.15

Price Target Upside77.97% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)-0.1

Revenue Forecast (FY)AU$6.00M

Bulls Say, Bears Say

Bulls Say

High Gross MarginsA reported 100% gross profit margin indicates very strong unit economics for the core imaging product. Durable high gross margins mean that if commercial adoption rises, revenue growth can translate quickly into incremental gross profit, helping cover fixed R&D and commercialization costs over time.

Moderate LeverageA moderate debt-to-equity ratio of 0.38 suggests the company has not over-levered its balance sheet. This level of leverage preserves financial flexibility to fund clinical trials, regulatory steps and commercialization without an immediate refinancing overhang, a durable advantage for near-term execution.

Unique Portable Brain-imaging ProductA differentiated product that targets pre-hospital and bedside brain imaging addresses persistent structural needs in stroke and TBI care. Portability and rapid diagnostics create a sustainable competitive position if regulatory and clinical validation proceeds, supporting long-term market adoption in emergency care pathways.

Bears Say

Steep Revenue DeclineA near 40% revenue contraction signals meaningful weakness in market adoption or sales execution. Persistently falling top-line reduces operating leverage, erodes runway for product development and commercial expansion, and makes it harder to demonstrate scalable demand to partners or payors over the coming months.

Negative Operating Cash FlowOngoing negative operating cash flow is a structural funding risk: it depletes reserves and forces external financing, dilution, or increased borrowing. That constrains the company’s ability to sustain trials, regulatory work and commercialization investments essential to converting its product potential into durable revenue streams.

Persistent Losses & Weak ProfitabilityNegative net profit and EBIT margins coupled with a negative return on equity show the business is not yet generating economic returns. Over a multi‑month horizon, continued losses undermine reinvestment capacity and investor flexibility, complicating scale-up and long-term competitiveness without a clear path to breakeven.

EMvision Medical Devices Ltd. News

S&P Dow Jones Revises March 2026 All Ordinaries Rebalance

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has provided an update. S&P Dow Jones Indices has updated its...

4d ago

EMV

S&P Dow Jones Indices Unveils March 2026 S&P/ASX Rebalance

The latest update is out from EMvision Medical Devices Ltd. ( ($AU:EMV) ). S&P Dow Jones Indices has...

8d ago

EMV

EMVision Issues 1H26 Presentation with Emphasis on Risks and Forward-Looking Uncertainty

The latest update is out from EMvision Medical Devices Ltd. ( ($AU:EMV) ). EMVision Medical Devices has released...

20d ago

EMV

EMvision Issues New Unquoted Options and Performance Rights Under Incentive Plan

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has issued an update. EMvision Medical Devices has issued 400,000 unquoted...

1M ago

EMV

EMVision Advances emu™ Brain Scanner Trials With Growing Global Stroke Hospital Network

EMvision Medical Devices Ltd. ( ($AU:EMV) ) just unveiled an update. EMVision reported strong progress across its clinical...

2M ago

EMV

EMvision Options Lapse, Simplifying Capital Structure

EMvision Medical Devices Ltd. ( ($AU:EMV) ) just unveiled an announcement. EMvision Medical Devices has notified the ASX...

2M ago

EMV

EMvision Director’s 300,000 Options Lapse at Expiry Without Exercise

The latest announcement is out from EMvision Medical Devices Ltd. ( ($AU:EMV) ). EMvision Medical Devices Ltd has...

2M ago

EMV

EMvision Announces Cessation of 250,000 Securities

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has issued an update. EMvision Medical Devices Ltd announced the cessation...

3M ago

EMV

EMvision Medical Devices Issues New Equity Options for Employee Incentive

EMvision Medical Devices Ltd. ( ($AU:EMV) ) just unveiled an announcement. EMvision Medical Devices Ltd has announced the...

4M ago

EMV

EMvision Director Acquires 200,000 Unlisted Options

EMvision Medical Devices Ltd. ( ($AU:EMV) ) has shared an update. EMvision Medical Devices Ltd announced a change...

4M ago

EMV

EMV FAQ

What was EMvision Medical Devices Ltd.’s price range in the past 12 months?

EMvision Medical Devices Ltd. lowest share price was AU$1.56 and its highest was AU$2.43 in the past 12 months.

What is EMvision Medical Devices Ltd.’s market cap?

EMvision Medical Devices Ltd.’s market cap is AU$146.84M.

When is EMvision Medical Devices Ltd.’s upcoming earnings report date?

EMvision Medical Devices Ltd.’s upcoming earnings report date is Sep 01, 2026 which is in 171 days.

How were EMvision Medical Devices Ltd.’s earnings last quarter?

EMvision Medical Devices Ltd. released its earnings results on Feb 22, 2026. The company reported -AU$0.044 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.044.

Is EMvision Medical Devices Ltd. overvalued?

According to Wall Street analysts EMvision Medical Devices Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does EMvision Medical Devices Ltd. pay dividends?

EMvision Medical Devices Ltd. does not currently pay dividends.

What is EMvision Medical Devices Ltd.’s EPS estimate?

EMvision Medical Devices Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does EMvision Medical Devices Ltd. have?

EMvision Medical Devices Ltd. has 92,938,610 shares outstanding.

What happened to EMvision Medical Devices Ltd.’s price movement after its last earnings report?

EMvision Medical Devices Ltd. reported an EPS of -AU$0.044 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of EMvision Medical Devices Ltd.?

Currently, no hedge funds are holding shares in AU:EMV

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

EMvision Medical Devices Ltd. Stock Smart Score

Neutral

Fundamentals

Return on Equity

-70.55%

Trailing 12-Months

Asset Growth

-35.03%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

EMvision Medical Devices Ltd.

EMvision Medical Devices Limited, a medical device company, engages in the research, development, and commercialization of imaging and diagnostic technology products. It develops a portable brain scanner for stroke diagnosis, monitoring, as well as other medical imaging needs. The company was incorporated in 2017 and is based in Macquarie Park, Australia.

EMvision Medical Devices Ltd. (EMV) Earnings & Revenues

Historic Earnings Reports

EMV Stock 12 Month Forecast

Average Price Target

AU$3.15

▲(77.97% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","2":"AU$2","3":"AU$3","4":"AU$4"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$3.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$3.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$3.15</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,1,2,3,4],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.755,1.8623076923076922,1.9696153846153845,2.0769230769230766,2.184230769230769,2.2915384615384613,2.398846153846154,2.506153846153846,2.6134615384615385,2.7207692307692306,2.8280769230769227,2.9353846153846153,3.042692307692308,{"y":3.15,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.755,1.8623076923076922,1.9696153846153845,2.0769230769230766,2.184230769230769,2.2915384615384613,2.398846153846154,2.506153846153846,2.6134615384615385,2.7207692307692306,2.8280769230769227,2.9353846153846153,3.042692307692308,{"y":3.15,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.755,1.8623076923076922,1.9696153846153845,2.0769230769230766,2.184230769230769,2.2915384615384613,2.398846153846154,2.506153846153846,2.6134615384615385,2.7207692307692306,2.8280769230769227,2.9353846153846153,3.042692307692308,{"y":3.15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1.38,"date":1667260800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.65,"date":1675209600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.35,"date":1680307200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.94,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.87,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.64,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.74,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.98,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.93,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.77,"date":1767225600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.775,"date":1769904000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1.755,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >